General Information
Version
6.2
Revision date
2024-02-20
Product name
2,6-Dichloro-3-hydroxybenzaldehyde
CAS No.
56962-14-2
1.2.1 Relevant identified uses
Laboratory chemicals, Synthesis of substances
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H310, H317, H319
Hazard statements
Code
Statements
H310
Fatal in contact with skin
Section 2
SECTION 2: Hazards identification
GHS Classification in Accordance with 29 CFR 1910 (OSHA HCS): Classification of the substance or mixture
Signal word
Danger
Hazard statements
H310 Fatal in contact with skin. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation.
Precautionary statements
P261 Avoid breathing dust. P262 Do not get in eyes, on skin, or on clothing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P272 Contaminated work clothing must not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P350 + P310 IF ON SKIN: Gently wash with plenty of soap and water. Immediately call a POISON CENTER or doctor/ physician. P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P337 + P313 If eye irritation persists: Get medical advice/ attention. P362 Take off contaminated clothing and wash before reuse. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
2.3 Other hazards
- none
2.1 Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) Acute toxicity, Dermal (Category 1), H310 Eye irritation (Category 2A), H319 Skin sensitization (Category 1), H317 For the full text of the H-Statements mentioned in this Section, see Section 16.